Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis

Abroad (travel likely)RecruitingPHASE2

Conditions

ESRD · CKD (Chronic Kidney Disease) Stage 5D

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Research Institute-McGill University Health Center, Montreal, Quebec, Canada
Contact: Study coordinator (Efrosyne Tsirella) · efrosyne.tsirella@muhc.mcgill.ca · 5149341934
Contact: Study coordinator (Norka Rios) · norka.rios@muhc.mcgill.ca · 514-934-1934

Study leads

Thomas A. Mavrakanas, MD, MSc.
Principal Investigator
Research Institute-McGill University of Health Centre

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

ESRD (End-Stage Renal Disease) · Kidney Transplantation · Xenotransplantation

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

A Prospecitve Multicenter, Observational Registry Study

Chronic Kidney Disease

Abroad (travel likely)Recruiting

Shanghai, China

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

Cardiovascular Diseases (CVD) · Chronic Kidney Disease · Metabolic Diseases

Abroad (travel likely)Recruiting

Fuzhou, China

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Diabetic Kidney Disease · Type 2 Diabetes · Chronic Kidney Disease

Abroad (travel likely)Recruiting

Halifax, Canada